Invention Grant
US07659263B2 Thienopyrrole compound and use thereof as HCV polymerase inhibitor
失效
噻吩并吡咯化合物及其作为HCV聚合酶抑制剂的用途
- Patent Title: Thienopyrrole compound and use thereof as HCV polymerase inhibitor
- Patent Title (中): 噻吩并吡咯化合物及其作为HCV聚合酶抑制剂的用途
-
Application No.: US11271136Application Date: 2005-11-10
-
Publication No.: US07659263B2Publication Date: 2010-02-09
- Inventor: Ryo Mizojiri , Takahiro Oka , Kenta Aoki , Satoru Noji , Yoko Matsumoto , Toshihiro Sato , Izuru Ando , Yasushi Niwa
- Applicant: Ryo Mizojiri , Takahiro Oka , Kenta Aoki , Satoru Noji , Yoko Matsumoto , Toshihiro Sato , Izuru Ando , Yasushi Niwa
- Applicant Address: JP Tokyo
- Assignee: Japan Tobacco Inc.
- Current Assignee: Japan Tobacco Inc.
- Current Assignee Address: JP Tokyo
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: JP2004-329780 20041112
- Main IPC: A61P1/16
- IPC: A61P1/16 ; A61P31/12 ; A61P43/00 ; A61K31/553 ; A61K31/5517 ; C07D498/12 ; C07D267/02 ; C07D495/14
Abstract:
The present invention relates to a thienopyrrole compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound as an active ingredient. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.
Public/Granted literature
- US20060167246A1 Thienopyrrole compound and use thereof as HCV polymerase inhibitor Public/Granted day:2006-07-27
Information query
